Lyra Therapeutics Inc (NASDAQ: LYRA) is -96.75% lower on its value in year-to-date trading and has touched a low of $0.16 and a high of $6.79 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The LYRA stock was last observed hovering at around $0.18 in the last trading session, with the day’s loss setting it -0.01%.
Currently trading at $0.17, the stock is -13.47% and -23.88% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 1.54 million and changing -6.54% at the moment leaves the stock -87.64% off its SMA200. LYRA registered -96.74% loss for a year compared to 6-month loss of -34.98%. The firm has a 50-day simple moving average (SMA 50) of $0.2245 and a 200-day simple moving average (SMA200) of $1.403505.
The stock witnessed a 1.31% gain in the last 1 month and extending the period to 3 months gives it a -39.47%, and is -13.04% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 9.49% over the week and 11.32% over the month.
Lyra Therapeutics Inc (LYRA) has around 88 employees, a market worth around $11.13M and $1.47M in sales. Profit margin for the company is -6635.76%. Distance from 52-week low is 4.68% and -97.49% from its 52-week high. The company has generated returns on investments over the last 12 months (-187.93%).
with sales reaching $204.8k over the same period.The EPS is expected to shrink by -6.83% this year, but quarterly earnings will post -2.52% year-over-year. Quarterly sales are estimated to grow 40.27% in year-over-year returns.
83.0 institutions hold shares in Lyra Therapeutics Inc (LYRA), with institutional investors hold 60.15% of the company’s shares. The shares outstanding are 65.46M, and float is at 54.79M with Short Float at 4.02%. Institutions hold 59.75% of the Float.
The top institutional shareholder in the company is PERCEPTIVE ADVISORS LLC with over 12.76 million shares valued at $3.53 million. The investor’s holdings represent 19.9302 of the LYRA Shares outstanding. As of 2024-06-30, the second largest holder is CITADEL ADVISORS LLC with 4.77 million shares valued at $1.32 million to account for 7.4562 of the shares outstanding. The other top investors are BLACKROCK INC. which holds 2.83 million shares representing 4.4211 and valued at over $0.78 million, while SAMSARA BIOCAPITAL, LLC holds 4.3434 of the shares totaling 2.78 million with a market value of $0.77 million.
